Bai H - Search Results

1

Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non-small cell lung cancer.

Zhao J, Zhuang W, Sun B, Bai H, Wang Z, Zhong J, Wan R, Liu L, Duan J, Wang J. Zhao J, et al. Among authors: bai h. Thorac Cancer. 2024 May;15(13):1050-1059. doi: 10.1111/1759-7714.15295. Epub 2024 Mar 25. Thorac Cancer. 2024. PMID: 38528429 Free PMC article.

2

Treatment of advanced non-small cell lung cancer with driver mutations: current applications and future directions.

Zhong J, Bai H, Wang Z, Duan J, Zhuang W, Wang D, Wan R, Xu J, Fei K, Ma Z, Zhang X, Wang J. Zhong J, et al. Among authors: bai h. Front Med. 2023 Feb;17(1):18-42. doi: 10.1007/s11684-022-0976-4. Epub 2023 Feb 23. Front Med. 2023. PMID: 36848029 Review.

3

Multi-omics indicators of long-term survival benefits after immune checkpoint inhibitor therapy.

Zhao J, Dong Y, Bai H, Bai F, Yan X, Duan J, Wan R, Xu J, Fei K, Wang J, Wang Z. Zhao J, et al. Among authors: bai h, bai f. Cell Rep Methods. 2023 Oct 23;3(10):100596. doi: 10.1016/j.crmeth.2023.100596. Epub 2023 Sep 21. Cell Rep Methods. 2023. PMID: 37738982 Free PMC article.

4

Biomarkers for Immunotherapy in Driver-Gene-Negative Advanced NSCLC.

Huang Y, Chau YF, Bai H, Wu X, Duan J. Huang Y, et al. Among authors: bai h. Int J Mol Sci. 2023 Sep 25;24(19):14521. doi: 10.3390/ijms241914521. Int J Mol Sci. 2023. PMID: 37833968 Free PMC article. Review.

5

Evaluation of first-line and salvage therapies for unresectable malignant mesothelioma: A systematic review and network meta-analysis.

Zhuang W, Liu L, Sun B, Bai H, Wang Z, Duan J, Wan R, Ma Z, Zhong J, Wang J. Zhuang W, et al. Among authors: bai h. Crit Rev Oncol Hematol. 2024 Jun;198:104372. doi: 10.1016/j.critrevonc.2024.104372. Epub 2024 Apr 26. Crit Rev Oncol Hematol. 2024. PMID: 38677356 Review.

6

Decision model for durable clinical benefit from front- or late-line immunotherapy alone or with chemotherapy in non-small cell lung cancer.

Zhao J, Wang L, Zhou A, Wen S, Fang W, Zhang L, Duan J, Bai H, Zhong J, Wan R, Sun B, Zhuang W, Lin Y, He D, Cui L, Wang Z, Wang J. Zhao J, et al. Among authors: bai h. Med. 2024 Aug 9;5(8):981-997.e4. doi: 10.1016/j.medj.2024.04.011. Epub 2024 May 22. Med. 2024. PMID: 38781965

7

Labeled-free quantitative proteomic analysis of cervical squamous cell carcinoma identifies potential protein biomarkers.

Bai H, Zheng H. Bai H, et al. PeerJ. 2024 Jun 28;12:e17444. doi: 10.7717/peerj.17444. eCollection 2024. PeerJ. 2024. PMID: 38952985 Free PMC article.

8

Rational discovery of a cancer neoepitope harboring the KRAS G12D driver mutation.

Bai P, Zhou Q, Wei P, Bai H, Chan SK, Kappler JW, Marrack P, Yin L. Bai P, et al. Among authors: bai h. Sci China Life Sci. 2021 Dec;64(12):2144-2152. doi: 10.1007/s11427-020-1888-1. Epub 2021 Mar 16. Sci China Life Sci. 2021. PMID: 33740187

9

Activating receptor KIR2DS2 bound to HLA-C1 reveals the novel recognition features of activating receptor.

Yang Y, Bai H, Wu Y, Chen P, Zhou J, Lei J, Ye X, Brown AJ, Zhou X, Shu T, Chen Y, Wei P, Yin L. Yang Y, et al. Among authors: bai h. Immunology. 2022 Mar;165(3):341-354. doi: 10.1111/imm.13439. Epub 2022 Jan 11. Immunology. 2022. PMID: 34967442 Free article.

10

Clearance of Intracellular Pathogens with Hyaluronic Acid Nanomicelles Responsive to H₂S and pH.

Luo J, Huang H, Jiang J, Zheng W, Chen P, Bai H. Luo J, et al. Among authors: bai h. Molecules. 2024 Dec 18;29(24):5971. doi: 10.3390/molecules29245971. Molecules. 2024. PMID: 39770059

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,920 results

Search Page

Filters